Cuvitru 01
Cuvitru Injection, Solution
Product Images NDC 0944-2850
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 19 technical images submitted to the FDA as part of the official labeling for Cuvitru (NDC 0944-2850). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Takeda Pharmaceuticals America, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Cuvitru 02
Cuvitru 03
Cuvitru 04
Cuvitru 05
Not available.*
Cuvitru 06
Cuvitru 07
Cuvitru 08
Cuvitru 09
Cuvitru 10
NDC: 0944-2850-02 is a prescription only medication called CUVITRU, used for subcutaneous administration, provided in vials with a 20% concentration of human immune globulin. The vial stopper is not made with natural rubber latex. It should be stored between 2°C to 8°C (36°F to 46°F) for up to 36 months and should not be frozen. It can be stored for up to 24 months at room temperature, not to exceed 25°C (77°F). Any unused portion should be discarded.*
Cuvitru 11
This is a description of a medication called CUVITRU that is a solution for subcutaneous administration and contains immune globulin subcutaneous. This medication is kept refrigerated at 2 to 8 degrees Celsius and can be stored at room temperature, not to exceed 25 percent and up to 24 months. The packaging contains a product code, and users should read the enclosed package insert for instructions. The medication contains no preservatives, and the vial stopper is not made with natural rubber.*
Cuvitru 12
Product name: CUVITRU. This is a solution for subcutaneous administration with 20% human immune globulin. The vial stopper is not made with natural rubber latex. The recommended storage temperature is 2°C to 8°C (36°F to 46°F) for up to 36 months. Do not freeze. Room temperature: not to exceed 25°C (77°F) for up to 24 months. The NDC number is 0944-2850-04. Unused portions should be discarded. errors are present in the text.*
Cuvitru 13
This is a description of a medical product named CUVITRU. It is a 20% Immune Globulin Subcutaneous solution used for immune globulin replacement therapy in people with primary immunodeficiency syndrome. The product is stabilized with 0.2 to 0.3 M glycine and comes in a single-dose vial containing 10 mL of the solution for subcutaneous administration. It is refrigerated at 2°C to 8°C and has a shelf life of up to 36 months. The text also includes information about the parent company, Shire and its subsidiaries.*
Cuvitru 14
Cuvitru 15
This is a product description for CUVITRU, a subcutaneous immune globulin treatment. The text provides the product code, contents, and instructions for use, as well as information about storage and preservation. The patient and physician are advised to discuss the risks and benefits of this product. The text also includes customer service information and pharmaceutical company details.*
Cuvitru 16
This text contains information about a medicine called "Immune Globulin Subcutaneous (Human) 20%" also known as CUVITRU. The medicine is available in a single-dose vial for subcutaneous administration. The vial stopper is not made with natural rubber latex. The medicine should be refrigerated between 2°C to 8°C (36°F to 46°F) for up to 36 months and should not be frozen. Discard any unused portion. The text also includes the trademarks of the manufacturer, Baxalta Incorporated. The remaining text is not readable.*
Cuvitru 17
Product Code 150 contains Immune Globulin Subcutaneous Human 20% (CUVITRU) which is a single-dose solution for subcutaneous administration. The stabilizer used is 0210 0.3M glycin, and there is no preservative in the solution. The vial stopper is not made up of natural rubber. It is advised to read the enclosed package inset and discard any unused portion. The solution should be refrigerated between 2°C to 8°C (36°F to 46°F) for up to 36 months, and it should not be frozen. At room temperature, it can be stored for up to 24 months, but the storage temperature should not exceed 25°C (77°F). The patient and physician should discuss the risks and benefits of this product. The text also includes some alphanumeric codes and the name of the product's manufacturer, Shire.*
Cuvitru 18
This is a description of CUVITRU, a prescription medicine used for subcutaneous administration to treat immune system disorders. It comes in a single-dose vial that should be refrigerated but not frozen. The stopper is not made with natural rubber latex. The medicine can be stored at room temperature not exceeding 25°C (77°F) for up to 24 months. BAXALTA® and CUVITRU® are trademarks of Baxalta Incorporated, and it's a subsidiary of Shire plc.*
Cuvitru 19
This is a product description for CUVITRU, which is a stabilized solution containing Immune Globulin Subcutaneous (Human) at 20%. It comes in a 50 mL bottle and is intended for subcutaneous administration. The package insert should be read for usage guidelines. It contains no preservatives and the vial stopper is not made with natural rubber latex. The patient and physician should have a discussion about the risks and benefits of using this product. The product should be refrigerated between 2° to 8°C for up to 36 months and not be frozen. It can also be stored at room temperature not exceeding 25°C for up to 24 months. The product is manufactured by Shire in WA, USA. However, the quality is poor.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
